The ASCCP Management Guidelines app provides interactive, evidence-based decision trees for cervical cancer screening on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#4
Medical · paid
Sentiment
4.8
9k reviews
Nemesis
DynaMed
The App DNA
What makes this app unique?
Clinicians use the app to replace static, text-heavy guidelines with a rapid, risk-based calculation tool that ensures compliance with the latest medical standards.
For Healthcare professionals, including clinicians and residents, specializing in colposcopy and cervical cancer prevention.
What does it look like?
Key features
Interactive decision trees for cervical cancer screening based on consensus guidelines.
Downloadable management algorithms for use in clinical settings without internet connectivity.
Access to clinical documents and EMR templates via member login.
How much does it cost?
The $14.99 price point serves as a direct revenue stream while acting as a gateway to broader society membership.
Velocity
Maintenance developmentnew contentUX improvementsShow more...
The app maintains a maintenance-level cadence, with only one release in the last 147 days and a total of nine versions identified over several years. Development is strictly focused on updating medical content and clinical guidelines rather than iterative feature expansion. With the latest release occurring 147 days ago and the Android platform showing no updates for 274 days, the development cycle is slow and reactive to external medical publication schedules. The project shows no signs of live operations or frequent feature iteration.
Who built it?
American Society for Colposcopy and Cervical Pathology
1 app tracked · Medical
Explore the full publisher profileUser Sentiment
What do users think recently?
Review voice lately leans frustrated. Users appreciate clinicians value the app as a daily diagnostic resource for evaluating pap smears and colposcopies, but report navigation regressions post-update force users to follow counter-intuitive pathways that lack clear clinical logic.
How are ratings & reviews evolving?
What users say, by theme
- Clinicians value the app as a daily diagnostic resource for evaluating pap smears and colposcopies
- Navigation regressions post-update force users to follow counter-intuitive pathways that lack clear clinical logic
70 of 103 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for ASCCP Management Guidelines
How's the Medical market?
ASCCP Management Guidelines holds a #30 Grossing rank in the US Medical category. The $14.99 price point positions it as a professional utility, though recent UI regressions threaten to undermine its value proposition against broader clinical reference tools.
Read the market outlookThe rivals identified
By EBSCO Publishing
DynaMed provides a direct clinical decision support alternative that mirrors the evidence-based, guideline-focused utility of the ASCCP app.
- Integrates broad clinical evidence across specialties rather than focusing exclusively on cervical cancer screening protocols.
- Utilizes a subscription-based institutional access model that lowers the barrier to entry for hospital-wide clinical adoption.
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for ASCCP Management Guidelines
Where is it heading?
The clinical reference market is consolidating around tools that offer deep EMR integration and institutional access, leaving single-purpose apps like ASCCP exposed. Unless the developer restores the intuitive visual flow charts and resolves the current UI obstructions, clinicians will likely migrate to broader, more stable reference tools, eroding the app's role as the standard-setting diagnostic utility.
- Navigation regressions force clinicians into loops, which erodes the daily active habit and drives negative sentiment.
- Inconsistent clinical recommendations between the app and web versions cause confusion, potentially leading to patient mismanagement.
The SWOT
- Consensus-based guidelines establish the app as the definitive clinical standard
- Member-only resource integration drives professional society loyalty
- Restoring visual flow charts would align with preferred clinical diagnostic workflows
- Implementing a clear data-reset function would improve patient-case management
Next best moves
Restore visual flow charts because users cite the current text-heavy format as harder to interpret → improve daily utility
+ 1 more prioritized moveThe counter-intuitive read
The app's primary vulnerability is not its $14.
Read the full takeFeature gaps
Institutional access model (available in DynaMed but absent here) +1
Since the last report: The app's commercial and user-experience standing has declined, evidenced by a drop in US Medical category ranking from #5 to #30 and the emergence of critical UI obstructions on Android devices.
Bottom line
Restoring the visual flow chart interface would address the primary driver of clinician frustration and restore the app's utility as a daily diagnostic tool. Prioritizing this UI restoration over new feature expansion is necessary to stabilize the user base and defend the society's standard-setting authority.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated